首页> 外文期刊>Journal of the American College of Surgeons >Natural killer cell activity and distant metastasis in rectal cancers treated surgically with and without neoadjuvant chemoradiotherapy.
【24h】

Natural killer cell activity and distant metastasis in rectal cancers treated surgically with and without neoadjuvant chemoradiotherapy.

机译:在有或没有新辅助放化疗的情况下,通过手术治疗的直肠癌的自然杀伤细胞活性和远处转移。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: We investigated whether impaired preoperative natural killer (NK) cell activity correlates with asynchronous distant metastasis after curative surgery for rectal cancers. In addition, we examined if preoperative chemoradiotherapy for rectal cancers impairs NK cell activity and contributes to the induction of distant metastasis. STUDY DESIGN: Preoperative NK cell activity was examined in 174 rectal cancer patients. All patients were enrolled in this study and followed until asynchronous distant metastasis occurred. RESULTS: The mean NK activity in patients with stage IV disease (n = 20) was significantly lower than seen in other stages. There were no differences among stage I to stage III patients. In stage III patients, the cumulative distant metastasis-free rate after curative surgery was significantly lower in cases with NK activity of 25% or less than those with more than 25%. Preoperative chemoradiotherapy for stage I to III patients significantly impaired NK cell activity (n = 39), andthe metastasis-positive ratio significantly increased among patients with stage II or stage III diseases (n = 30). Multivariate analysis indicated that dichotomized NK cell activity was a significant risk factor that is associated with distant metastasis as well as nodal involvement. CONCLUSIONS: In primary rectal cancers, NK cell activity is not necessarily impaired in accordance with the disease progression. It is considered an important background factor for developing asynchronous distant metastases in stage III rectal cancers. Neoadjuvant chemoradiotherapy impaired NK cell activity in selected patients, suggesting the necessity of concurrent immunotherapy for better outcomes.
机译:背景:我们调查了直肠癌根治性手术后受损的术前自然杀伤(NK)细胞活性是否与异步远处转移相关。另外,我们检查了直肠癌的术前放化疗是否会损害NK细胞的活性并有助于诱导远处转移。研究设计:对174例直肠癌患者的术前NK细胞活性进行了检查。所有患者均入选本研究,并随访直至发生异步远处转移。结果:IV期疾病患者(n = 20)的平均NK活性明显低于其他阶段。 I期至III期患者之间无差异。在III期患者中,NK活动度为25%或以下的患者远高于25%以上的患者,治愈性手术后的累积远距离无转移率明显更低。 I至III期患者的术前放化疗显着损害了NK细胞活性(n = 39),而II期或III期疾病患者的转移阳性率显着增加(n = 30)。多变量分析表明,二分之一的NK细胞活性是与远处转移以及淋巴结转移相关的重要危险因素。结论:在原发性直肠癌中,NK细胞活性不一定根据疾病进展而受损。它被认为是III期直肠癌发生异步远距离转移的重要背景因素。新辅助放化疗会损害部分患者的NK细胞活性,提示必须同时进行免疫治疗才能取得更好的结局。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号